ELISA Kit for Thrombin/Antithrombin Complex (TAT)

Specificity

This assay has high sensitivity and excellent specificity for detection of Thrombin/Antithrombin Complex (TAT).
No significant cross-reactivity or interference between Thrombin/Antithrombin Complex (TAT) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Thrombin/Antithrombin Complex (TAT) and the recovery rates were calculated by comparing the measured value to the expected amount of Thrombin/Antithrombin Complex (TAT) in samples.

Matrix Recovery range (%) Average(%)
sodium citrate plasma(n=5) 81-90 86

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Thrombin/Antithrombin Complex (TAT) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Thrombin/Antithrombin Complex (TAT) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Thrombin/Antithrombin Complex (TAT) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
sodium citrate plasma(n=5) 94-101% 90-101% 90-104% 90-98%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
IUBMB LIFE Genetic repression of mouse VEGF expression regulates coagulation cascade. PubMed: 21086498
Thrombosis Research Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice ScienceDirect: S0049384811004166
Journal of Thrombosis and Haemostasis High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality Wiley: source
3 Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling Nature: 20120329
Am J Respir Cell Mol Bio Prolonged Exposure to Sphingosine 1–Phosphate Receptor-1 Agonists Exacerbates Vascular Leak, Fibrosis, and Mortality after Lung Injury PubMed: PMC2993087
PLoS One Host Defense Peptides of Thrombin Modulate Inflammation and Coagulation in Endotoxin-Mediated Shock and Pseudomonas aeruginosa Sepsis PubMed: PMC3521733
Haemetology Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India Pubmed: 23992124
Am J Transl Res. Selected hemostatic parameters in patients with pancreatic tumors. Pubmed:Pmc4297344
PLOS ONE TFPI1 Mediates Resistance to Doxorubicin in Breast Cancer Cells by Inducing a Hypoxic-Like Response Pubmed:24489651
Leukemia Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs) Pubmed:24667943
Anesthesia &amp; Analgesia Thrombomodulin Improved Liver Injury, Coagulopathy, and Mortality in an Experimental Heatstroke Model in Mice Pubmed:24781566
Cell Transplantation Evidence of a Pivotal Role for the Distal Part of the Complement Cascade in the Diurnal Release of Hematopoietic Stem Cells Into Peripheral Blood Pubmed:26087465
European Journal of Pharmacology (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coaCavia (Guinea pig )lation Pubmed:27343380
J Thromb Haemost. Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis. pubmed:27813324
Blood Cells, Inflammation and Infection Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury pubmed:29202212
SCIENCE TRANSLATIONAL MEDICINE Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension pubmed:28148841
32 Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target pubmed:28289017
Thrombosis andHaemostasis Nebulized anti-coagulants as a therapy for acute lung injury and acute respiratory distress syndrome Pubmed: 29202212
Thrombosis Research The circadian rhythm of selected parameters of the hemostasis system in healthy people
Experimental Neurobiology Transduced Tat-aldose Reductase Protects Hippocampal Neuronal Cells against Oxidative Stress-induced Damage Pubmed: 31698553
LIVER TRANSPLANTATION The impact of dabigatran treatment on sinusoidal protection against hepatic ischemia‐reperfusion injury in mice Pubmed: 33108682
Am J Physiol Heart Circ Physiol Doxorubicin contributes to thrombus formation and vascular injury via enhancing platelet functions in vivo Pubmed: 32469636
Intensive Care Medicine Experimental Preservation of renal endothelial integrity and reduction of renal edema by aprotinin does not preserve renal perfusion and function following experimental … 34169407
Intensive Care Med Exp Complement factor D is linked to platelet activation in human and rodent sepsis 34396466
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
EPA831Hu61 Eukaryotic Thrombin/Antithrombin Complex (TAT) Positive Control; Immunogen; SDS-PAGE; WB.
RPA831Hu01 Recombinant Thrombin/Antithrombin Complex (TAT) Positive Control; Immunogen; SDS-PAGE; WB.
MAA831Hu21 Monoclonal Antibody to Thrombin/Antithrombin Complex (TAT) WB
MAA831Hu24 Monoclonal Antibody to Thrombin/Antithrombin Complex (TAT) WB; IHC; ICC; IP.
MAA831Hu25 Monoclonal Antibody to Thrombin/Antithrombin Complex (TAT) WB; IHC; ICC; IP.
MAA831Hu22 Monoclonal Antibody to Thrombin/Antithrombin Complex (TAT) WB; IHC; ICC; IP.
MAA831Hu23 Monoclonal Antibody to Thrombin/Antithrombin Complex (TAT) WB; IHC; ICC; IP.
MAA831Hu27 Monoclonal Antibody to Thrombin/Antithrombin Complex (TAT) WB; IHC; ICC; IP.
SEA831Hu ELISA Kit for Thrombin/Antithrombin Complex (TAT) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA831Hu Multiplex Assay Kit for Thrombin/Antithrombin Complex (TAT) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.